Researchers in the UK have developed a way to coax microscopic particles and droplets into precise patterns by harnessing the power of sound in air. The implications for printing, especially in the fields of medicine and electronics, are far-reaching.
Mouse hematopoietic stem cell (HSC) transplantation has involved adult and fetal mice and recipient HSC depletion using irradiation and other DNA damaging approaches. Exploiting their understanding of genetics and hematopoiesis, researchers from the University of Tsukuba have developed a new, embryonic HSC transplantation model that lacks HSCs. They have shown high donor cell chimerism in recipients and that these cells are functional. This report describes a model for exploring HSCs and hematopoiesis.
Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.
Corticosteroids in kidney transplant patients may not be needed past a seven-day post surgery period, according to a University of Cincinnati College of Medicine study.
Scientists have found that comparing the ratio of two immune molecules helped predict the likelihood of transplant rejection in 339 patients who received kidney transplants, the only curative treatment for late-stage kidney failure.
Researchers have discovered a blood biomarker that predicts kidney transplant rejection with a lead time of about eight months, which could give doctors an opportunity to intervene and prevent permanent damage, potentially using an existing medication.
POSTECH professor Sung-Min Park's research team is developing a fully automated glucose management system that goes beyond the limits.
A potential new treatment to protect immunosuppressed patients from human cytomegalovirus (HCMV) has been discovered by scientists at the University of Cambridge. Their study shows that certain epigenetic inhibitors expose and help to destroy dormant HCMV infections, which often reactivate to cause serious illness and death in these vulnerable groups. Subject to clinical trials, their proposed 'shock and kill' treatment strategy offers hope to transplant patients across the world.
Latest discovery could improve development of future stem cell therapies and cancer treatments.
Scientists at the University of Cambridge have used a technique to grow bile duct organoids - often referred to as 'mini-organs' - in the lab and shown that these can be used to repair damaged human livers. This is the first time that the technique has been used on human organs.